Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Predicts Impending Heart Attack

By LabMedica International staff writers
Posted on 01 Apr 2012
A blood test was devised that identifies specific cells that flake off when the blood vessel walls weaken and signal the initial stages of acute myocardial infarction (MI).

The blood test that can predict whether a person is at high risk of suffering from a heart attack and can provide the doctor and patient with this vital information up to two weeks before an acute MI or cardiac episode is likely to occur.

Scientists at Scripps Translational Science Institute (La Jolla, CA, USA) enrolled patients between January 2010 and February 2011, who presented to the emergency room with ST-segment elevation MI (STEMI) at four regional medical centers and had blood drawn for circulating endothelial cells (CECs) characterization. More...
The study involved 94 participants, 50 of them had had a heart attack while the other 44 were healthy controls. The CECs were identified using the CellTracks system, which consists of an automated CellTracks Auto Prep sample preparation device and a CellTracks Analyzer II (CTA II) image analysis platform. Fluorescence intensity measurements of fixed CECs from CellSearch were carried out in a four-step process. Total ribonucleic acids (RNAs) were isolated from CECs according to the standard TRIzol method for gene expression analysis.

The CEC blood levels among those who had had a heart attack were over four times higher when compared to those in the healthy control group. Not only CEC blood levels were much higher among the heart attack patients but also their CECs had changed; they had either become larger, misshapen, and/or many had multiple nuclei. During the initial stages of a heart attack, the walls of the blood vessel weaken, they become eroded, attracting inflammatory cells, which in turn harm and damage the endothelial cells that line the inside of blood vessels. Endothelial cells are those that form the cellular lining of a tissue. Severe inflammation causes the CECs to mutate; they clump together, break off and get into the bloodstream.

The CellSearch System used in this study is a commercially available rare cell isolation platform manufactured by Veridex (North Raritan, NJ, USA). Eric J. Topol, MD, a senior author of the study, said, "For the first time, we can isolate these cells through techniques that were not available in 1999. They are like a window into the process that underlies an imminent heart attack.” In a considerable number of cases, CECs sloughing off the interior wall of a blood vessel become involved in a series of events that results in a blood clot. Professor Topol added, "It is the clot that cuts off the blood supply and serves as the proximate cause of a heart attack. Eventually, a plaque ruptures and a blood clot develops." The study was published on March 21 2012, in the journal Science Translational Medicine.

Related Links:

Scripps Translational Science Institute
Veridex



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.